SCHEMBL3793263

SCHEMBL3793263

O=C(Nc1ccc(Cl)cc1NC(=O)c1ccccc1)c1ccccc1

nearest known ligand 0.76

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KCNMA1 Q12791 2/20 0.76
MEN1 O00255 2/20 0.68
KMT2A Q03164 2/20 0.68
SERPINE1 P05121 4/20 0.66
KDM4E B2RXH2 1/20 0.65
NPSR1 Q6W5P4 1/20 0.65
RXFP1 Q9HBX9 1/20 0.65
MAPT P10636 2/20 0.61
NPC1 O15118 1/20 0.60
RAB9A P51151 1/20 0.60
AKR1C4 P17516 1/20 0.57
AKR1C3 P42330 1/20 0.57
AKR1C2 P52895 1/20 0.57
AKR1C1 Q04828 1/20 0.57
EPHX1 P07099 1/20 0.57
KCNK3 O14649 1/20 0.57
KCNK9 Q9NPC2 1/20 0.57
ALDH1A1 P00352 1/20 0.56
LMNA P02545 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22955886 0.90 KCNMA1 (0.68) KCNMA1MEN1KMT2ASERPINE1KDM4E
SCHEMBL8819672 0.88 MEN1 (0.82) KCNMA1MEN1KMT2ASERPINE1KDM4E
SCHEMBL8804658 0.88 KDM4E (0.82) KCNMA1MEN1KMT2ASERPINE1KDM4E
SCHEMBL14476825 0.86 KCNMA1 (1.00) KCNMA1MEN1KMT2ANPC1RAB9A
Iodide SCHEMBL30758629 0.86 MEN1 (0.80) KCNMA1MEN1KMT2ASERPINE1KDM4E
SCHEMBL1495948 0.86 KCNMA1 (0.77) KCNMA1MEN1KMT2ASERPINE1KDM4E
SCHEMBL11819922 0.85 MAPT (0.68) KCNMA1KMT2ASERPINE1KDM4ENPSR1
SCHEMBL15333445 0.85 RAB9A (0.65) KCNMA1MEN1KMT2ASERPINE1KDM4E
SCHEMBL6351321 0.85 SERPINE1 (0.89) KCNMA1MEN1KMT2ASERPINE1KDM4E
SCHEMBL1310106 0.85 GRIK1 (0.74) KCNMA1MEN1KMT2ASERPINE1NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100087680-A1 METHOD FOR PRODUCING BIARYL COMPOUND SUMITOMO CHEMICAL COMPANY LIMITED (JP) 2010-04-08 US disclosed
EP-1914221-A1 PROCESS FOR PRODUCING BIARYL COMPOUND Sumitomo Chemical Company, Limited (JP) 2008-04-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100087680-A1 METHOD FOR PRODUCING BIARYL COMPOUND NISCH, BLVRB, BBOX1 KCNMA1 4544/4885MEN1 174/4885KMT2A 1474/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.